Dutch Translation of the Yost Self-Report Lower Extremity Lymphedema Screening Questionnaire in Women.

Dutch translation Lymphedema gynecological cancer self-reported questionnaire

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
28 Jun 2024
Historique:
received: 15 06 2024
accepted: 27 06 2024
medline: 13 7 2024
pubmed: 13 7 2024
entrez: 13 7 2024
Statut: epublish

Résumé

Validated questionnaires of self-reported LEL are important in the assessment and diagnosis of LEL. The aim of this study was to validate and translate a Dutch version of the screening questionnaire, the LELSQ developed and validated by Yost et al. Methods: We tested the questionnaire on a group of healthy women and a group of patients diagnosed with LEL. The translation was carried out using the forward and backward method from English to Dutch. SPSS (IBM corp, Armonk, New York, NY, USA) version 28.0.1.0 (001) was used for statistical analysis in the process of validation. The internal consistency was assessed by determining Cronbach's alpha. The reliability was tested by test-retest reliability. The validity was determined by ROC analysis, and content and face validity were evaluated. The internal consistency score in both groups had a strong value (0.83 to 0.90). The test-retest reliability was also strong in both groups. Face and content validity showed the LELSQ is an easy, understandable questionnaire that is not too time-consuming in the early detection of LEL. The ROC analysis showed an AUC value of 0.93, indicating strong validity. The validated Dutch translation showed high values for internal consistency, test-retest reliability, and validity, which allows us to implement the questionnaire in the early detection of LEL after gynecological cancer treatment.

Sections du résumé

BACKGROUND BACKGROUND
Validated questionnaires of self-reported LEL are important in the assessment and diagnosis of LEL. The aim of this study was to validate and translate a Dutch version of the screening questionnaire, the LELSQ developed and validated by Yost et al. Methods: We tested the questionnaire on a group of healthy women and a group of patients diagnosed with LEL. The translation was carried out using the forward and backward method from English to Dutch.
STATISTICAL ANALYSES METHODS
SPSS (IBM corp, Armonk, New York, NY, USA) version 28.0.1.0 (001) was used for statistical analysis in the process of validation. The internal consistency was assessed by determining Cronbach's alpha. The reliability was tested by test-retest reliability. The validity was determined by ROC analysis, and content and face validity were evaluated.
RESULTS RESULTS
The internal consistency score in both groups had a strong value (0.83 to 0.90). The test-retest reliability was also strong in both groups. Face and content validity showed the LELSQ is an easy, understandable questionnaire that is not too time-consuming in the early detection of LEL. The ROC analysis showed an AUC value of 0.93, indicating strong validity.
CONCLUSIONS CONCLUSIONS
The validated Dutch translation showed high values for internal consistency, test-retest reliability, and validity, which allows us to implement the questionnaire in the early detection of LEL after gynecological cancer treatment.

Identifiants

pubmed: 39001458
pii: cancers16132396
doi: 10.3390/cancers16132396
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : by Kom op Tegen Kanker (Stand up to Cancer), the Flemish cancer society
ID : project ID : 12149

Auteurs

Tina Decorte (T)

Department of Physical Medicine and Rehabilitation and Clinic for Lymphatic Disorders, Ghent University Hospital, 109000 Ghent, Belgium.

Charlotte Van Calster (C)

Department of Rehabilitation Sciences, University of Leuven and Lymphoedema Center, Leuven University Hospital, 493000 Leuven, Belgium.

Caren Randon (C)

Department of Thoracic and Vascular Surgery and Clinic for Lymphatic Disorders, Ghent University Hospital, 109000 Ghent, Belgium.

Vickie Van Besien (V)

Department of Physical Therapy and Motor Rehabilitation, Ghent University, 109000 Ghent, Belgium.

Mathilde Ketels (M)

Department of Physical Medicine and Rehabilitation, Ghent University Hospital, 109000 Ghent, Belgium.

Luc Vanden Bossche (L)

Department of Physical Medicine and Rehabilitation, Ghent University Hospital, 109000 Ghent, Belgium.

Mieke De Schryver (M)

Clinic for Lymphatic Disorders, Ghent University Hospital, 109000 Ghent, Belgium.

Chris Monten (C)

Department of Radiation Oncology and Clinic for Lymphatic Disorders, Ghent University Hospital, 109000 Ghent, Belgium.

Classifications MeSH